1. Home
  2. LEGN vs AES Comparison

LEGN vs AES Comparison

Compare LEGN & AES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • AES
  • Stock Information
  • Founded
  • LEGN 2014
  • AES 1981
  • Country
  • LEGN United States
  • AES United States
  • Employees
  • LEGN N/A
  • AES N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • AES Electric Utilities: Central
  • Sector
  • LEGN Health Care
  • AES Utilities
  • Exchange
  • LEGN Nasdaq
  • AES Nasdaq
  • Market Cap
  • LEGN 5.4B
  • AES 7.1B
  • IPO Year
  • LEGN 2020
  • AES 1991
  • Fundamental
  • Price
  • LEGN $35.64
  • AES $11.50
  • Analyst Decision
  • LEGN Strong Buy
  • AES Hold
  • Analyst Count
  • LEGN 13
  • AES 8
  • Target Price
  • LEGN $75.17
  • AES $12.71
  • AVG Volume (30 Days)
  • LEGN 2.0M
  • AES 16.9M
  • Earning Date
  • LEGN 08-08-2025
  • AES 07-31-2025
  • Dividend Yield
  • LEGN N/A
  • AES 6.11%
  • EPS Growth
  • LEGN N/A
  • AES 146.43
  • EPS
  • LEGN N/A
  • AES 1.83
  • Revenue
  • LEGN $728,303,000.00
  • AES $12,119,000,000.00
  • Revenue This Year
  • LEGN $65.49
  • AES $3.95
  • Revenue Next Year
  • LEGN $53.76
  • AES $2.93
  • P/E Ratio
  • LEGN N/A
  • AES $6.27
  • Revenue Growth
  • LEGN 112.46
  • AES N/A
  • 52 Week Low
  • LEGN $27.34
  • AES $9.46
  • 52 Week High
  • LEGN $60.87
  • AES $20.30
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 57.79
  • AES 60.96
  • Support Level
  • LEGN $32.42
  • AES $10.02
  • Resistance Level
  • LEGN $36.91
  • AES $10.92
  • Average True Range (ATR)
  • LEGN 1.42
  • AES 0.47
  • MACD
  • LEGN 0.02
  • AES 0.07
  • Stochastic Oscillator
  • LEGN 67.58
  • AES 87.72

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About AES The AES Corporation

AES is a global power company that operates in 15 countries. Its generation portfolio as of year-end 2023 totals over 35 gigawatts, including renewable energy (53%), gas (27%), coal (18%), and oil (2%). AES has majority ownership and operates six electric utilities distributing power to more than 2.5 million customers.

Share on Social Networks: